Skip to content
GLP-1 Savers
Menu

Head-to-head · Value Score

Gimme Care vs FORM by GBY

Two GLP-1 deals, scored on the same six factors. Gimme Care lands a Value Score of 91, FORM by GBY a 61. Here's who gives you the honest lower price — and where each one bites back.

★ Better value

Gimme Care

#5 · Grade A · Best Value

Est. first month

$130/mo

Save ~90% vs brand-name
Get this deal Full Gimme Care review →
VS

FORM by GBY

#344 · Grade C · Watch List

Est. first month

$299/mo

Save ~78% vs brand-name
Get this deal Full FORM by GBY review →

The verdict

Better value: Gimme Care

Gimme Care takes it on Value Score, 91 to 61 an est. $130/mo first month, with no teaser step-up baked in. FORM by GBY isn't out of it: Shoppers who want the widest single-account menu and are willing to complete intake to learn what the branded and adjacent-care lines actually cost.

Our #1 overall:Neither of these is our top pick — that's CoreAge Rx (Value Score 93).See why →

Deal-by-deal

The numbers that decide it. Green ✓ marks the stronger side on each line.

DealGimme CareFORM by GBY
Value Score91 (A)61 (C)
Est. first month$130/mo$299/mo
Save vs brand-name~90%~78%
Semaglutide$130/mo$299/mo (compounded, no dose tiers published)
Tirzepatide$163/moNot disclosed (Zepbound membership offered, drug cost not published)
Both moleculesYesYes
PricingFlat — no step-upWatch
CoverageAll 50 states48 states + DC (excludes Alaska, Mississippi)

Factor by factor

The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.

93
Lowest Real Price
48
Gimme Care: 93. FORM by GBY: 48.
88
No Teaser-Rate Bait
32
Gimme Care: 88. FORM by GBY: 32.
98
Nationwide Availability
84
Gimme Care: 98. FORM by GBY: 84.
92
Both Molecules
70
Gimme Care: 92. FORM by GBY: 70.
84
Easy Cancellation
70
Gimme Care: 84. FORM by GBY: 70.
82
Reputation
62
Gimme Care: 82. FORM by GBY: 62.

Gimme Care

Genuinely cheap on both molecules ($130 / $163) with a LegitScript-certified pharmacy and all-50-state reach.

Why it's a deal

  • Low flat price on both molecules ($130 sema / $163 tirz)
  • LegitScript-certified pharmacy
  • Available in all 50 states

The fine print

  • No brand-name option — compounded only
  • No oral/sublingual form

FORM by GBY

The broadest menu on the board — compounded and branded GLP-1s, NAD+/sermorelin, and hair loss on one account — but the advertised Wegovy "$95/mo" is a membership fee only, not the drug cost, and almost nothing else is priced.

Why it's a deal

  • Widest published menu on this board: compounded GLP-1 (injectable and oral), branded Wegovy/Zepbound, NAD+/sermorelin/GHK-Cu/glutathione, and hair loss on one account
  • Compounded semaglutide has a real, published sticker price ($299/mo)
  • LegitScript-approved and HIPAA-compliant badges displayed

The fine print

  • ⚠ The advertised Wegovy "$95/mo" is a MEMBERSHIP FEE ONLY — the actual medication cost is billed separately and is not disclosed anywhere on the page. Do not read $95 as the all-in Wegovy price
  • No published price for tirzepatide, Zepbound, NAD+, sermorelin, or the hair-loss line — compounded semaglutide is the only dosed figure on the whole site
  • No named medical director or doctors; the pharmacy is identified only as generic "US licensed pharmacies," not by name
  • Does not serve Alaska or Mississippi
Get the Gimme Care deal Get the FORM by GBY deal

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.

Neither one the right fit? Every program that outscores Gimme Care is ranked on the Gimme Care alternatives board, and the same list for the other side is on alternatives to FORM by GBY.

More head-to-heads

← All comparisons

Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.